cover
Contact Name
Hardyanto Soebono
Contact Email
hardyanto@ugm.ac.id
Phone
+62274-560300
Journal Mail Official
jmedscie@ugm.ac.id
Editorial Address
Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Farmako Street, Sekip Utara ,Yogyakarta 55281 Indonesia
Location
Kab. sleman,
Daerah istimewa yogyakarta
INDONESIA
Indonesian Journal of Biomedicine and Clinical Sciences
ISSN : -     EISSN : 30323134     DOI : https://doi.org/10.22146/inajbcs.v56i01.11961
Core Subject : Health, Science,
Indonesian Journal of Biomedicine and Clinical Sciences (InaJBCS) aims to promote the translational of basic research into clinical studies and of clinical evidence into practice. InaJBCS publishes studies that substantially enhance our standing of disease etiology and physiology; the development of prognostic and diagnostic technologies; trials that test the efficacy of specific interventions and those that compare different treatments. InaJBCS invites authors to submit articles in the fields of biomedical sciences including biomedical genetics, bioinformatics, cardiovascular medicine, endocrinology, gastroenterology, geriatrics, infectious diseases, medical oncology, physiology, pharmacology and toxicology, and phytomedicine medicine.
Articles 152 Documents
Bowen’s disease to invasive squamous cell carcinoma on a non–sun-exposed lower extremity in an elderly woman: a clinical continuum Dyah Ayu Mira Oktarina; Amelia Pungky; Rizky Rahma Wijayanti; Silvia Rakhmadani; Hanggoro Tri Rinonce; Niken Indrastuti
Indonesian Journal of Biomedicine and Clinical Sciences Vol 58 No 4 (2026): in press
Publisher : Published by Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/inajbcs.v58i4.29079

Abstract

Cutaneous squamous cell carcinoma (cSCC) and Bowen’s disease (BD) represent biologically related stages of keratinocyte carcinogenesis. Although ultraviolet (UV) radiation is the dominant etiologic factor, cSCC arising in non–sun-exposed sites through alternative pathogenic mechanisms is increasingly recognized, particularly in elderly patients. The co-existence of BD and invasive cSCC at non–sun-exposed locations remains uncommon. We report a case of a 70-year-old woman presenting with persistent pruritic erythematous plaques on the left lower leg and right thigh. The lesions initially appeared as small itchy patches and progressively enlarged over two years despite prior treatment for eczema. Clinical examination of the left lower leg revealed an erythematous plaque with brownish crust-covered erosion and indistinct margins. On the right thigh, there was an erythematous plaque with a yellowish crusted ulcer and well-defined borders. Dermoscopic evaluation of the left lower leg lesion revealed clustered glomerular vessels on a diffuse erythematous background. While on the right thigh, keratin-associated structures with polymorphous irregular vessels are seen. Histopathological evaluation of the left lower leg lesion exhibited dysplastic keratinocytes throughout the entire epidermal layer without basal membrane invasion, consistent with Bowen’s disease. On the right thigh, histopathological examination revealed a well-differentiated invasive cutaneous squamous cell carcinoma, characterized by tumor cells arranged in solid nests infiltrating the basal membrane into the dermis with keratin pearls, clear intercellular bridges, and numerous mitotic FIGUREs. This case highlights the continuum between BD and cSCC at non–sun-exposed sites and underscores the diagnostic challenges posed by chronic inflammatory mimickers. Persistent or treatment-refractory plaques in elderly patients warrant early dermoscopic evaluation and histopathologic confirmation. Recognition of non–UV-driven carcinogenic pathways is important for accurate diagnosis and timely management.
Endothelin-converting enzyme-1 mRNA expression correlates with downregulation of kallikrein and upregulation of endothelin a receptor after ureteral ligation in mice: ECE-1 downregulates Kallikrein expression upon UUO Nur Arfian; Dian Prasetyo Wibisono; Ghassani Rahman; Valerie Hassani Putri; Ardiles Varian; FBA Ummiyah; Eryna Ayu Nugra Desita; Nungki Anggorowati; Dwi Cahyani Ratna Sari
Indonesian Journal of Biomedicine and Clinical Sciences Vol 58 No 4 (2026): in press
Publisher : Published by Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/inajbcs.v58i4.33823

Abstract

Endothelin-converting enzyme-1(ECE-1), endothelin A receptor (ETAR) and kallikrein-kinin system (KKS) may play roles in the pathophysiology of kidney disease. ECE-1, an important protein responsible for endothelin-1 (ET-1) production, may contribute to renal fibrosis due to kidney obstruction. However, KKS has shown protective roles in kidney injury. In this study, we investigated the relationship between Kallikrein, ETAR, and ECE-1 mRNA expression in a unilateral ureteral obstruction (UUO) model in mice. Twenty male Swiss Webster mice (age 8-12 weeks, body weight 30-40 grams) were divided into 3 groups: negative control/Sham-operated group (SO, n=6), mice with UUO which were sacrificed on day 7 (D7UUO, n=7), and day 14 (D14UUO, n=7). Tubular injury score was analysed by Periodic Acid Schiff (PAS) staining, and immunohistochemistry of α-SMA was conducted to examine myofibroblast formation. ECE-1, Kallikrein, and ETAR mRNA expressions were quantified using reverse transcriptase-PCR (RT-PCR). UUO induced tubular injury and destruction of renal architecture, with higher scores in the D7UUO and D14UUO groups (p<0.001). Myofibroblast area fraction also revealed a significantly higher area fraction in D7UUO (p<0.001) and D14UUO (p<0.001) compared to SO. Furthermore, UUO promoted ECE-1 upregulation that was associated with Kallikrein downregulation. We also found a significantly upregulated expression of ETAR in the D14UUO group compared to the SO and D7UUO groups. Ureteral ligation may induce upregulation of ECE-1 and ETAR expression and downregulation of Kallikrein expression, leading to their contributions in kidney disease.